TY - JOUR
T1 - Positron emission tomography (PET)
T2 - An update on applications in breast cancer
AU - Wahl, Richard L.
PY - 1998/8
Y1 - 1998/8
N2 - Positron Emission Tomography (PET) is an imaging method which detects alterations in tumor physiology and displays them in an anatomically precise manner. Historically, the method has been a research tool, but it is being increasingly applied to clinical imaging problems. PET, using the glucose analog 18-F-fluoro-2-deoxy-D-glucose (FDG), has been applied most widely and shows promise in detecting primary cancers, characterizing breast masses, staging for axillary metastases, evaluating for systemic metastases, and following response to therapy. This review summarizes the current status of this technique, which is in rapid evolution as new tracers and new imaging cameras become available.
AB - Positron Emission Tomography (PET) is an imaging method which detects alterations in tumor physiology and displays them in an anatomically precise manner. Historically, the method has been a research tool, but it is being increasingly applied to clinical imaging problems. PET, using the glucose analog 18-F-fluoro-2-deoxy-D-glucose (FDG), has been applied most widely and shows promise in detecting primary cancers, characterizing breast masses, staging for axillary metastases, evaluating for systemic metastases, and following response to therapy. This review summarizes the current status of this technique, which is in rapid evolution as new tracers and new imaging cameras become available.
UR - http://www.scopus.com/inward/record.url?scp=0031656010&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031656010&partnerID=8YFLogxK
U2 - 10.3233/BD-1998-103-416
DO - 10.3233/BD-1998-103-416
M3 - Article
C2 - 15687572
AN - SCOPUS:0031656010
SN - 0888-6008
VL - 10
SP - 165
EP - 175
JO - Breast Disease
JF - Breast Disease
IS - 3-4
ER -